NEUPATH HEALTH INC (NPTH.CA) Stock Fundamental Analysis
TSX-V:NPTH - TSX Venture Exchange - CA64133P1009 - Common Stock - Currency: CAD
Overall NPTH gets a fundamental rating of 3 out of 10. We evaluated NPTH against 16 industry peers in the Health Care Providers & Services industry. The financial health of NPTH is average, but there are quite some concerns on its profitability. NPTH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
NPTH had negative earnings in the past year.
NPTH had a positive operating cash flow in the past year.
NPTH had negative earnings in each of the past 5 years.
Of the past 5 years NPTH 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -1.79%, NPTH is doing worse than 62.50% of the companies in the same industry.
NPTH has a Return On Equity (-3.64%) which is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 3.73%, NPTH is doing good in the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.79% | ||
| ROE | -3.64% | ||
| ROIC | 3.73% |
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NPTH has a Operating Margin (2.18%) which is in line with its industry peers.
Looking at the Gross Margin, with a value of 19.11%, NPTH is doing worse than 62.50% of the companies in the same industry.
In the last couple of years the Gross Margin of NPTH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.18% | ||
| PM (TTM) | N/A | ||
| GM | 19.11% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NPTH is destroying value.
NPTH has about the same amout of shares outstanding than it did 1 year ago.
NPTH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NPTH has an improved debt to assets ratio.
2.2 Solvency
NPTH has an Altman-Z score of 1.47. This is a bad value and indicates that NPTH is not financially healthy and even has some risk of bankruptcy.
With a decent Altman-Z score value of 1.47, NPTH is doing good in the industry, outperforming 68.75% of the companies in the same industry.
The Debt to FCF ratio of NPTH is 4.02, which is a neutral value as it means it would take NPTH, 4.02 years of fcf income to pay off all of its debts.
NPTH has a Debt to FCF ratio of 4.02. This is amongst the best in the industry. NPTH outperforms 81.25% of its industry peers.
NPTH has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
NPTH has a better Debt to Equity ratio (0.49) than 81.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 4.02 | ||
| Altman-Z | 1.47 |
ROIC/WACC0.67
WACC5.54%
2.3 Liquidity
A Current Ratio of 1.15 indicates that NPTH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.15, NPTH belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
A Quick Ratio of 1.15 indicates that NPTH should not have too much problems paying its short term obligations.
NPTH has a better Quick ratio (1.15) than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.15 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
NPTH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -161.54%.
Looking at the last year, NPTH shows a quite strong growth in Revenue. The Revenue has grown by 10.56% in the last year.
Measured over the past years, NPTH shows a small growth in Revenue. The Revenue has been growing by 7.96% on average per year.
EPS 1Y (TTM)-161.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.45%
Revenue 1Y (TTM)10.56%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%10.57%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
NPTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NPTH indicates a rather cheap valuation: NPTH is cheaper than 93.75% of the companies listed in the same industry.
87.50% of the companies in the same industry are more expensive than NPTH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.96 | ||
| EV/EBITDA | 5.65 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NPTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:NPTH (6/4/2025, 7:00:00 PM)
0.26
-0.01 (-1.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners24.33%
Inst Owner ChangeN/A
Ins Owners1.49%
Ins Owner ChangeN/A
Market Cap14.74M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.2 | ||
| P/FCF | 4.96 | ||
| P/OCF | 3.78 | ||
| P/B | 0.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.65 |
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.05
FCFY20.14%
OCF(TTM)0.07
OCFY26.47%
SpS1.32
BVpS0.37
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.79% | ||
| ROE | -3.64% | ||
| ROCE | 5.18% | ||
| ROIC | 3.73% | ||
| ROICexc | 4.34% | ||
| ROICexgc | 20.73% | ||
| OM | 2.18% | ||
| PM (TTM) | N/A | ||
| GM | 19.11% | ||
| FCFM | 3.98% |
ROA(3y)-3.74%
ROA(5y)-5.69%
ROE(3y)-7.64%
ROE(5y)-10.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.42%
GM growth 5Y-1.04%
F-Score6
Asset Turnover1.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 4.02 | ||
| Debt/EBITDA | 2.62 | ||
| Cap/Depr | 40.29% | ||
| Cap/Sales | 1.25% | ||
| Interest Coverage | 6.73 | ||
| Cash Conversion | 98.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.15 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z | 1.47 |
F-Score6
WACC5.54%
ROIC/WACC0.67
Cap/Depr(3y)39.19%
Cap/Depr(5y)26.48%
Cap/Sales(3y)1.5%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-161.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.56%
Revenue growth 3Y6.16%
Revenue growth 5Y7.96%
Sales Q2Q%10.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y155.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1079.87%
FCF growth 3Y3.23%
FCF growth 5YN/A
OCF growth 1Y321.73%
OCF growth 3Y10.75%
OCF growth 5YN/A